succinylacetone has been researched along with Coagulation, Disseminated Intravascular in 1 studies
succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To confirm the diagnosis of tyrosinemia, quantitative urinary succinylacetone was measured." | 1.31 | [Liver failure with coagulopathy in an infant with tyrosinemia]. ( Amir, J; Campino, G; Nussinovitch, M; Shapira, R; Voluvitz, B, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nussinovitch, M | 1 |
| Campino, G | 1 |
| Shapira, R | 1 |
| Voluvitz, B | 1 |
| Amir, J | 1 |
1 other study available for succinylacetone and Coagulation, Disseminated Intravascular
| Article | Year |
|---|---|
[Liver failure with coagulopathy in an infant with tyrosinemia].
Topics: Biomarkers; Disseminated Intravascular Coagulation; Heptanoates; Humans; Infant; Liver Failure; Male | 2001 |